Managed care pharmaceutical industry faced with costs challenge

By Ben Mouncer
Dealing with rising costs is the biggest challenge facing the managed care pharmaceutical industry in the United States, according to experts. Managed...

Dealing with rising costs is the biggest challenge facing the managed care pharmaceutical industry in the United States, according to experts.
 
Managed Healthcare Executive (MHE) spoke with over 200 insiders for their second annual managed care pharmacy survey, which was conducted in the first quarter of 2017.

It concluded that spiralling costs are presenting the most significant issues with regards to care and sustainability, especially with the rapidly-increasing demand for specialty drugs.

Drawing insight from Alliance of Community Health Plans research, MHE says that an annual 15-20% surge in demand for specialty drugs can be expected in the coming years.

This has been put down to a variety of contributing factors including a growing population, an increase in product pricing at manufacturer level and patients choosing new specialty treatment.

The experts also gave their views on potential solutions to the problem, with many advocating increased collaboration as a method to drive down costs.

“Collaboration could indeed have a positive effect on drug prices in the both the near and long term,” said Will Hinde, managing director, West Monroe Partners, a business and technology consulting firm with a focus that includes healthcare. 

“Collaboration in the near term between the payer, provider, and patient would seem to offer hope for near-term price relief to consumers through better payer/provider coordination. 

“Significant barriers exist to this collaboration, however, as each of these constituent groups jockey to ‘own’ patient and health data from various sources.”

Share

Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma